{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T03:22:40Z","timestamp":1778124160467,"version":"3.51.4"},"reference-count":99,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Medical Microbiology"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.ijmm.2014.08.016","type":"journal-article","created":{"date-parts":[[2014,8,30]],"date-time":"2014-08-30T20:37:02Z","timestamp":1409431022000},"page":"894-901","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Influenza, a One Health paradigm\u2014Novel therapeutic strategies to fight a zoonotic pathogen with pandemic potential"],"prefix":"10.1016","volume":"304","author":[{"given":"Stephan","family":"Ludwig","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Zell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Schwemmle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Herold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijmm.2014.08.016_bib0005","doi-asserted-by":"crossref","first-page":"4694","DOI":"10.1128\/JVI.03123-12","article-title":"Nucleozin targets cytoplasmic trafficking of viral ribonucleoprotein-Rab11 complexes in influenza A virus infection","volume":"87","author":"Amorim","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0010","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1172\/JCI66125","article-title":"PAR-1 contributes to the innate immune response during viral infection","volume":"123","author":"Antoniak","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0015","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/135965350701200S04.1","article-title":"Influenza virus susceptibility and resistance to oseltamivir","volume":"12","author":"Aoki","year":"2007","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0020","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/irv.12094","article-title":"Low-dose oral interferon alpha as prophylaxis against viral respiratory illness: a double-blind, parallel controlled trial during an influenza pandemic year","volume":"7","author":"Bennett","year":"2013","journal-title":"Influenza Other Respir. Viruses"},{"key":"10.1016\/j.ijmm.2014.08.016_bib0025","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.antiviral.2013.07.018","article-title":"New-generation screening assays for the detection of anti-influenza compounds targeting viral and host functions","volume":"100","author":"Beyleveld","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0030","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1074\/jbc.M113.469239","article-title":"Inhibition of p38 mitogen-activated protein kinase impairs influenza virus-induced primary and secondary host gene responses and protects mice from lethal H5N1 infection","volume":"289","author":"Borgeling","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0035","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1001\/jama.295.8.joc60020","article-title":"Adamantane resistance among influenza A viruses isolated early during the 2005\u20132006 influenza season in the United States","volume":"295","author":"Bright","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.ijmm.2014.08.016_bib0040","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1164\/rccm.200812-1837OC","article-title":"Macrophage tumor necrosis factor-alpha induces epithelial expression of granulocyte-macrophage colony-stimulating factor: impact on alveolar epithelial repair","volume":"180","author":"Cakarova","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0045","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.2217\/fmb.13.128","article-title":"Influenza virus nucleoprotein: structure, RNA binding, oligomerization and antiviral drug target","volume":"8","author":"Chenavas","year":"2013","journal-title":"Future Microbiol."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0050","first-page":"721","article-title":"JNK2 and IKKbeta are required for activating the innate response to viral infection","volume":"11","author":"Chu","year":"1999","journal-title":"Immunology"},{"key":"10.1016\/j.ijmm.2014.08.016_bib0055","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nrd773","article-title":"Protein kinases \u2013 the major drug targets of the twenty-first century?","volume":"1","author":"Cohen","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0060","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1177\/135965350701200S07.1","article-title":"Neuraminidase inhibitors and their role in avian and pandemic influenza","volume":"12","author":"Crusat","year":"2007","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0065","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.bcp.2006.09.014","article-title":"Acyclic nucleoside phosphonates: past, present and future. Bridging chemistry to HIV, HBV, HCV, HPV, adeno-, herpes-, and poxvirus infections: the phosphonate bridge","volume":"73","author":"De Clercq","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0070","doi-asserted-by":"crossref","first-page":"e57576","DOI":"10.1371\/journal.pone.0057576","article-title":"Evidence of cross-reactive immunity to 2009 pandemic influenza A virus in workers seropositive to swine H1N1 influenza viruses circulating in Italy","volume":"8","author":"De Marco","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ijmm.2014.08.016_bib0075","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/nature07745","article-title":"The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit","volume":"458","author":"Dias","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.ijmm.2014.08.016_bib0080","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.antiviral.2011.08.002","article-title":"Antiviral activity of the MEK-inhibitor U0126 against pandemic H1N1v and highly pathogenic avian influenza virus in vitro and in vivo","volume":"92","author":"Droebner","year":"2011","journal-title":"Antiviral Res."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0085","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3201\/eid1606.100138","article-title":"Swine influenza A vaccines, pandemic (H1N1) 2009 virus, and crossreactivity","volume":"16","author":"D\u00fcrrwald","year":"2010","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0090","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/j.1462-5822.2009.01309.x","article-title":"A new player in a deadly game: influenza viruses and the PI3K\/Akt signalling pathway","volume":"11","author":"Ehrhardt","year":"2009","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0095","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1111\/cmi.12108","article-title":"The NF-kappaB inhibitor SC75741 efficiently blocks influenza virus propagation and confers a high barrier for development of viral resistance","volume":"15","author":"Ehrhardt","year":"2013","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0100","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1083\/jcb.151.5.951","article-title":"Caspases disrupt the nuclear-cytoplasmic barrier","volume":"151","author":"Faleiro","year":"2000","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0105","doi-asserted-by":"crossref","first-page":"6903","DOI":"10.4049\/jimmunol.180.10.6903","article-title":"Agonists of proteinase-activated receptor-2 enhance IFN-gamma-inducible effects on human monocytes: role in influenza A infection","volume":"180","author":"Feld","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0110","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.antiviral.2013.09.015","article-title":"Favipiravir (T-705), a novel viral RNA polymerase inhibitor","volume":"100","author":"Furuta","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0115","doi-asserted-by":"crossref","first-page":"15366","DOI":"10.1073\/pnas.1107906108","article-title":"Inhibition of influenza virus replication via small molecules that induce the formation of higher-order nucleoprotein oligomers","volume":"108","author":"Gerritz","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0120","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3201\/eid1703.100851","article-title":"Swine influenza virus antibodies in humans, western Europe","volume":"17","author":"Gerloff","year":"2009","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0125","doi-asserted-by":"crossref","first-page":"7801","DOI":"10.1128\/JVI.00724-07","article-title":"Peptide-mediated interference with influenza A virus polymerase","volume":"81","author":"Ghanem","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0130","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nsmb.1421","article-title":"The structural basis for cap binding by influenza virus polymerase subunit PB2","volume":"15","author":"Guilligay","year":"2008","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0135","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.antiviral.2013.03.006","article-title":"Combination of MEK inhibitors and oseltamivir leads to synergistic antiviral effects after influenza A virus infection in vitro","volume":"98","author":"Haasbach","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0140","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.antiviral.2013.06.008","article-title":"The NF-kappaB inhibitor SC75741 protects mice against highly pathogenic avian influenza A virus","volume":"99","author":"Haasbach","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0145","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/nature07120","article-title":"Crystal structure of the polymerase PA(C)-PB1(N) complex from an avian influenza H5N1 virus","volume":"454","author":"He","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ijmm.2014.08.016_bib0150","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1164\/rccm.201311-2041LE","article-title":"Inhaled granulocyte\/macrophage colony-stimulating factor as treatment of pneumonia-associated acute respiratory distress syndrome","volume":"189","author":"Herold","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0155","doi-asserted-by":"crossref","first-page":"e1003188","DOI":"10.1371\/journal.ppat.1003188","article-title":"Macrophage-expressed IFN-\u03b2 contributes to apoptotic alveolar epithelial cell injury in severe influenza virus pneumonia","volume":"9","author":"H\u00f6gner","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0160","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1164\/rccm.201012-2036OC","article-title":"GM-CSF in the lung protects against lethal influenza infection","volume":"184","author":"Huang","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0165","doi-asserted-by":"crossref","first-page":"b5106","DOI":"10.1136\/bmj.b5106","article-title":"Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis","volume":"339","author":"Jefferson","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.ijmm.2014.08.016_bib0170","first-page":"CD008965","article-title":"Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children","volume":"4","author":"Jefferson","year":"2014","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0175","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/nbt.1638","article-title":"Identification of influenza A nucleoprotein as an antiviral target","volume":"28","author":"Kao","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0180","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1172\/JCI61667","article-title":"PAR1 contributes to influenza A virus pathogenicity in mice","volume":"123","author":"Khoufache","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0185","doi-asserted-by":"crossref","first-page":"7795","DOI":"10.4049\/jimmunol.0803743","article-title":"Protective role for protease-activated receptor-2 against influenza virus pathogenesis via an IFN-gamma-dependent pathway","volume":"182","author":"Khoufache","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0190","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(04)16934-1","article-title":"Resistant influenza A viruses in children treated with oseltamivir: descriptive study","volume":"364","author":"Kiso","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ijmm.2014.08.016_bib0195","doi-asserted-by":"crossref","first-page":"4629","DOI":"10.1021\/jm500598u","article-title":"Aminoadamantanes with Persistent in Vitro Efficacy against H1N1 (2009) Influenza A","volume":"57","author":"Kolocouris","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0200","doi-asserted-by":"crossref","first-page":"e1002831","DOI":"10.1371\/journal.ppat.1002831","article-title":"Structural analysis of specific metal chelating inhibitor binding to the endonuclease domain of influenza pH1N1 (2009) polymerase","volume":"8","author":"Kowalinski","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0205","doi-asserted-by":"crossref","first-page":"11236","DOI":"10.1073\/pnas.0801967105","article-title":"Apoptosis leads to a degradation of vital components of active nuclear transport and a dissociation of the nuclear lamina","volume":"105","author":"Kramer","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0210","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1002\/jmv.21869","article-title":"Prevalence of antibodies to swine influenza viruses in humans with occupational exposure to pigs, Thuringia, Germany, 2008\u20132009","volume":"82","author":"Krumbholz","year":"2010","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0215","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00430-013-0309-y","article-title":"Prevalence of antibodies to European porcine influenza viruses in humans living in high pig density areas of Germany","volume":"203","author":"Krumbholz","year":"2013","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0220","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.1128\/JVI.02453-08","article-title":"Intranasal administration of alpha interferon reduces seasonal influenza A virus morbidity in ferrets","volume":"83","author":"Kugel","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0225","doi-asserted-by":"crossref","first-page":"9880","DOI":"10.1128\/JVI.00909-08","article-title":"NF-kappaB signaling differentially regulates influenza virus RNA synthesis","volume":"82","author":"Kumar","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0230","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/QCO.0b013e3283199797","article-title":"The potential impact of neuraminidase inhibitor resistant influenza","volume":"21","author":"Lackenby","year":"2008","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0235","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.vetmic.2013.09.024","article-title":"Reassortants of the pandemic (H1N1) 2009 virus and establishment of a novel porcine H1N2 influenza virus, lineage in Germany","volume":"167","author":"Lange","year":"2013","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0240","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.coviro.2014.03.001","article-title":"H7N9: a low pathogenic avian influenza A virus infecting humans","volume":"5C","author":"Liu","year":"2014","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0245","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/sita.200600114","article-title":"Influenza viruses and MAP kinase cascades \u2013 novel targets for antiviral therapy?","volume":"7","author":"Ludwig","year":"2007","journal-title":"Signal Transduct."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0250","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1515\/BC.2008.148","article-title":"Influenza viruses and the NF-kappaB signaling pathway \u2013 towards a novel concept of antiviral therapy","volume":"389","author":"Ludwig","year":"2008","journal-title":"Biol. Chem."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0255","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S1471-4914(02)00010-2","article-title":"Influenza virus induced signaling pathways \u2013 targets for antiviral therapy?","volume":"9","author":"Ludwig","year":"2003","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0260","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1462-5822.2005.00678.x","article-title":"Ringing the alarm bells: signalling and apoptosis in influenza virus infected cells","volume":"8","author":"Ludwig","year":"2006","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0265","doi-asserted-by":"crossref","first-page":"11166","DOI":"10.1128\/JVI.76.21.11166-11171.2002","article-title":"The influenza A virus NS1 protein inhibits activation of Jun N-terminal kinase and AP-1 transcription factors","volume":"76","author":"Ludwig","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0270","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0014-5793(04)00108-5","article-title":"MEK inhibition impairs influenza B virus propagation without emergence of resistant variants","volume":"561","author":"Ludwig","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0275","doi-asserted-by":"crossref","first-page":"16707","DOI":"10.1074\/jbc.M510233200","article-title":"Membrane accumulation of influenza A virus hemagglutinin triggers nuclear export of the viral genome via protein kinase Calpha-mediated activation of ERK signaling","volume":"281","author":"Marjuki","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00003246-200001000-00001","article-title":"Modulation of neutrophil apoptosis by granulocyte colony-stimulating factor and granulocyte\/macrophage colony-stimulating factor during the course of acute respiratory distress syndrome","volume":"28","author":"Matute-Bello","year":"2000","journal-title":"Critic. care Med."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0285","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1111\/j.1462-5822.2007.00902.x","article-title":"Acetylsalicylic acid (ASA) blocks influenza virus propagation via its NF-kappaB-inhibiting activity","volume":"9","author":"Mazur","year":"2007","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0290","doi-asserted-by":"crossref","first-page":"6247","DOI":"10.1073\/pnas.1119817109","article-title":"Small molecule inhibitors of influenza A and B viruses that act by disrupting subunit interactions of the viral polymerase","volume":"109","author":"Muratore","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0295","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1515\/hsz-2011-0270","article-title":"Small molecule inhibitors of the c-Jun N-terminal kinase (JNK) possess antiviral activity against highly pathogenic avian and human pandemic influenza A viruses","volume":"393","author":"Nacken","year":"2012","journal-title":"Biol. Chem."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0495","doi-asserted-by":"crossref","first-page":"8843","DOI":"10.1128\/JVI.00424-14","article-title":"Activation of c-jun N-Terminal Kinase upon Influenza A Virus (IAV) Infection Is Independent of Pathogen-Related Receptors but Dependent on Amino Acid Sequence Variations of IAV NS1","volume":"88","author":"Nacken","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0300","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1099\/vir.0.79958-0","article-title":"Active NF-kappaB signalling is a prerequisite for influenza virus infection","volume":"85","author":"Nimmerjahn","year":"2004","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0305","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/nature07225","article-title":"The structural basis for an essential subunit interaction in influenza virus RNA polymerase","volume":"454","author":"Obayashi","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ijmm.2014.08.016_bib0310","doi-asserted-by":"crossref","first-page":"6639","DOI":"10.1038\/sj.onc.1207883","article-title":"Lung-specific expression of active Raf kinase results in increased mortality of influenza A virus-infected mice","volume":"23","author":"Olschlager","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.ijmm.2014.08.016_bib0315","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1177\/095632020201300401","article-title":"New millennium antivirals against pandemic and epidemic influenza: the neuraminidase inhibitors","volume":"13","author":"Oxford","year":"2002","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0320","doi-asserted-by":"crossref","first-page":"6853","DOI":"10.1038\/sj.onc.1203239","article-title":"Activators and target genes of Rel\/NF-kappaB transcription factors","volume":"18","author":"Pahl","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.ijmm.2014.08.016_bib0325","doi-asserted-by":"crossref","first-page":"e1000196","DOI":"10.1371\/journal.ppat.1000196","article-title":"Influenza A virus inhibits type I IFN signaling via NF-kappaB-dependent induction of SOCS-3 expression","volume":"4","author":"Pauli","year":"2008","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0330","doi-asserted-by":"crossref","first-page":"8997","DOI":"10.1074\/jbc.R500020200","article-title":"The M2 proton channels of influenza A and B viruses","volume":"281","author":"Pinto","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0335","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1039\/B611613M","article-title":"Controlling influenza virus replication by inhibiting its proton channel","volume":"3","author":"Pinto","year":"2007","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0340","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.antiviral.2011.05.009","article-title":"Inhibition of influenza virus-induced NF-kappaB and Raf\/MEK\/ERK activation can reduce both virus titers and cytokine expression simultaneously in vitro and in vivo","volume":"92","author":"Pinto","year":"2011","journal-title":"Antiviral Res."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0345","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.antiviral.2013.04.008","article-title":"Development of cellular signaling pathway inhibitors as new antivirals against influenza","volume":"98","author":"Planz","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0350","doi-asserted-by":"crossref","first-page":"4871","DOI":"10.1128\/JVI.75.10.4871-4877.2001","article-title":"MEK-specific inhibitor U0126 blocks spread of Borna disease virus in cultured cells","volume":"75","author":"Planz","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0355","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/35060098","article-title":"Influenza virus propagation is impaired by inhibition of the Raf\/MEK\/ERK signalling cascade","volume":"3","author":"Pleschka","year":"2001","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0360","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1164\/rccm.2009005","article-title":"A randomized phase II trial of granulocyte-macrophage colony-stimulating factor therapy in severe sepsis with respiratory dysfunction","volume":"166","author":"Presneill","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0365","doi-asserted-by":"crossref","first-page":"13298","DOI":"10.1128\/JVI.00868-11","article-title":"Targeting of the influenza A virus polymerase PB1-PB2 interface indicates strain-specific assembly differences","volume":"85","author":"Reuther","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0370","doi-asserted-by":"crossref","first-page":"5738","DOI":"10.1021\/jm5005804","article-title":"Easily accessible polycyclic amines that inhibit the wild-type and amantadine-resistant mutants of the M2 channel of influenza A virus","volume":"57","author":"Rey-Carrizo","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0375","doi-asserted-by":"crossref","first-page":"5180","DOI":"10.4049\/jimmunol.0804198","article-title":"Essential impact of NF-kappaB signaling on the H5N1 influenza A virus-induced transcriptome","volume":"183","author":"Schmolke","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0380","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/10533","article-title":"Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo","volume":"5","author":"Sebolt-Leopold","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0385","doi-asserted-by":"crossref","first-page":"16515","DOI":"10.1073\/pnas.1113107108","article-title":"E339. R416 salt bridge of nucleoprotein as a feasible target for influenza virus inhibitors","volume":"108","author":"Shen","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0390","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2567.2011.03443.x","article-title":"Role of proteinase-activated receptor-2 in anti-bacterial and immunomodulatory effects of interferon-gamma on human neutrophils and monocytes","volume":"133","author":"Shpacovitch","year":"2011","journal-title":"Immunology"},{"key":"10.1016\/j.ijmm.2014.08.016_bib0395","doi-asserted-by":"crossref","first-page":"L447","DOI":"10.1152\/ajplung.00415.2010","article-title":"TLR4-dependent GM-CSF protects against lung injury in Gram-negative bacterial pneumonia","volume":"302","author":"Standiford","year":"2012","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0400","doi-asserted-by":"crossref","first-page":"5346","DOI":"10.4049\/jimmunol.1101413","article-title":"Local delivery of GM-CSF protects mice from lethal pneumococcal pneumonia","volume":"187","author":"Steinwede","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0405","doi-asserted-by":"crossref","first-page":"L343","DOI":"10.1152\/ajplung.00276.2011","article-title":"GM-CSF provides autocrine protection for murine alveolar epithelial cells from oxidant-induced mitochondrial injury","volume":"302","author":"Sturrock","year":"2012","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0410","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1038\/emboj.2009.138","article-title":"Structural insight into the essential PB1-PB2 subunit contact of the influenza virus RNA polymerase","volume":"28","author":"Sugiyama","year":"2009","journal-title":"EMBO J."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0415","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1471-2334-11-134","article-title":"Systematic review of influenza resistance to the neuraminidase inhibitors","volume":"11","author":"Thorlund","year":"2011","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0420","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1038\/ncomms2589","article-title":"The role and assembly mechanism of nucleoprotein in influenza A virus ribonucleoprotein complexes","volume":"4","author":"Turrell","year":"2013","journal-title":"Nat. Comm."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0425","doi-asserted-by":"crossref","first-page":"3652","DOI":"10.1172\/JCI62139","article-title":"Alveolar epithelial cells orchestrate DC function in murine viral pneumonia","volume":"122","author":"Unkel","year":"2012","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0430","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4049\/jimmunol.0904170","article-title":"H5N1 virus activates signaling pathways in human endothelial cells resulting in a specific imbalanced inflammatory response","volume":"186","author":"Viemann","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0435","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1073\/pnas.1216526110","article-title":"Structure and inhibition of the drug-resistant S31N mutant of the M2 ion channel of influenza A virus","volume":"110","author":"Wang","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0440","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.tim.2011.10.003","article-title":"The changing nature of avian influenza A virus (H5N1)","volume":"20","author":"Watanabe","year":"2012","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0445","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1152\/physrev.1999.79.1.143","article-title":"Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human","volume":"79","author":"Widmann","year":"1999","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0450","doi-asserted-by":"crossref","first-page":"16704","DOI":"10.1074\/jbc.M110.102533","article-title":"Limited compatibility of polymerase subunit interactions in influenza A and B viruses","volume":"285","author":"Wunderlich","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0455","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1128\/AAC.01419-10","article-title":"Identification of high-affinity PB1-derived peptides with enhanced affinity to the PA protein of influenza A virus polymerase","volume":"55","author":"Wunderlich","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0460","doi-asserted-by":"crossref","first-page":"e7517","DOI":"10.1371\/journal.pone.0007517","article-title":"Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication","volume":"4","author":"Wunderlich","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ijmm.2014.08.016_bib0465","doi-asserted-by":"crossref","first-page":"30931","DOI":"10.1074\/jbc.M403258200","article-title":"NF-kappaB-dependent induction of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and Fas\/FasL is crucial for efficient influenza virus propagation","volume":"279","author":"Wurzer","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0470","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1093\/emboj\/cdg279","article-title":"Caspase 3 activation is essential for efficient influenza virus propagation","volume":"22","author":"Wurzer","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0475","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/23948","article-title":"The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta","volume":"396","author":"Yin","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.ijmm.2014.08.016_bib0480","first-page":"241","article-title":"The 2009 pandemic influenza virus: where did it come from, where is it now, and where is it going?","volume":"370","author":"York","year":"2013","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.ijmm.2014.08.016_bib0485","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/nature07720","article-title":"Crystal structure of an avian influenza polymerase PA(N) reveals an endonuclease active site","volume":"458","author":"Yuan","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.ijmm.2014.08.016_bib0490","first-page":"29","article-title":"Genetics, evolution, and the zoonotic capacity of European Swine influenza viruses","volume":"370","author":"Zell","year":"2013","journal-title":"Curr. Top. Microbiol. Immunol."}],"container-title":["International Journal of Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1438422114001155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1438422114001155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T00:43:50Z","timestamp":1650069830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1438422114001155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":99,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S1438422114001155"],"URL":"https:\/\/doi.org\/10.1016\/j.ijmm.2014.08.016","relation":{},"ISSN":["1438-4221"],"issn-type":[{"value":"1438-4221","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influenza, a One Health paradigm\u2014Novel therapeutic strategies to fight a zoonotic pathogen with pandemic potential","name":"articletitle","label":"Article Title"},{"value":"International Journal of Medical Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijmm.2014.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}